The antinociceptive effect of intravenous imipramine in colorectal distension-induced visceral pain in rats: The role of serotonergic and noradrenergic receptors

Ilkaya F., Bilge S. S., Bozkurt A., Bas D. B., Erdal A., Çiftcioğlu E., ...More

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, vol.122, pp.1-6, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 122
  • Publication Date: 2014
  • Doi Number: 10.1016/j.pbb.2014.02.017
  • Journal Name: PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1-6
  • Keywords: Imipramine, Serotonergic receptors, Adrenergic receptors, Visceral pain, Colorectal distension, Antinociception, 5-HT3 RECEPTORS, TRICYCLIC ANTIDEPRESSANTS, NOCICEPTIVE TRANSMISSION, SPINAL-CORD, MICE, SUBTYPES, ANALGESIA, AMITRIPTYLINE, HYPERALGESIA, METAANALYSIS
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

It has been shown that imipramine, a tricyclic antidepressant (TCA), is a potent analgesic agent. However, the effect of imipramine on visceral pain has not been extensively investigated. In the current study, our aim was to characterise the putative analgesic effect of intravenous imipramine on visceral pain in rats. Our second aim was to assess the involvement of serotonergic (5-HT2,3, 4) and noradrenergic (alpha(2A, 2B, 2C)) receptor subtypes in this putative antinociceptive effect of imipramine. Male Sprague Dawley rats (250-300 g) were implanted with venous catheters for drug administration and implanted with enamelled nichrome electrodes for electromyography of the external oblique muscles. Noxious visceral stimulation was applied via by colorectal distension (CRD). The visceromotor responses (VMRs) to CRD were quantified electromyographically before and after imipramine administration at 5, 15, 30, 60,90 and 120 min. In the antagonist groups, the agents were administered 10 min before imipramine. The administration of imipramine (5-40 mg/kg) produced a dose-dependent reduction in VMR. The administration of yohimbine (a nonselective alpha(2)-adrenoceptor antagonist, 1 mg/lg), BRL-44408 (an alpha(2A)-adrenoceptor antagonist 1 mg/kg) or MK-912 (an alpha(2C)-adrenoceptor antagonist, 300 mu g/kg) but not imiloxan (an alpha(2B)-adrenoceptor antagonist, 1 mg/kg) inhibited the antinociceptive effect of imipramine (20 mg/kg). Additionally, ketanserin (a 5-HT2 receptor antagonist, 0.5, 1, and 2 mg/kg) and GR113808 (a 5-HT4 receptor antagonist, 1 mg/kg) enhanced, and ondansetron (a 5-HT3 receptor antagonist 0.5, 1, and 2 mg/kg) failed to alter the imipramine-induced antinociceptive effect. Our data demonstrated that, in the CDR-induced rat visceral pain model, intravenous imipramine appeared to have antinociceptive potential and that alpha(2A)-/alpha(2C)-adrenoceptors and 5-HT2/5-HT4 receptors may be responsible for the antinociceptive effect of imipramine on visceral pain in rats. (C) 2014 Elsevier Inc All rights reserved.